chronic kidney disease 5 phase
Conditions
Interventions
Treatment group of compound Jixuecao Sijunzi decoction:Oral compound Jixuecao Sijunzi decoction mixture
Control group:None
Sponsors
Hangzhou Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Patients with chronic kidney disease stage 5 peritoneal dialysis (PD) received CAPD treatment for more than 3 months; 2.Aged 20 to 70 years; 3.The presence of intestinal dysfunction, according to the gastrointestinal symptom Grading Scale (GSRS); 4.Proton-pump inhibitor has not been used in the last two months; 5.Not taking antibiotics within 2 weeks; 6.Patients are willing to accept the research project and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients with malignant tumor and severe multiple organ failure; 2.Unable to cooperate; 3.Known allergic to drugs; 4.Patients who switched to peritoneal dialysis after receiving hemodialysis or kidney transplantation; 5.Severe infection (pneumonia, peritonitis, etc., should be treated with antibiotics), drug suspension, and hemodialysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Human feces 16SrRNA gene; | — |
Countries
China
Contacts
Public ContactWang Yuhui
Hangzhou Hospital of Traditional Chinese Medicine
Outcome results
None listed